NCT02251652View on ClinicalTrials.gov

Safety and Efficacy of Ingenol Mebutate 0.05% Gel When Used After Cryotherapy in the Hypertrophic Actinic Keratoses

PHASE4CompletedINTERVENTIONAL

Enrollment

16

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

August 31, 2015

Conditions

Actinic Keratoses

Interventions

DRUG

Ingenol Mebutate

Ingenol mebutate 0.05% gel

PROCEDURE

Cryotherapy

1-2 sprays, 5 seconds each, with a 5 second interval

Trial Locations (1)

11370

Icahn School of Medicine at Mount Sinai, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

LEO Pharma

INDUSTRY

lead

Icahn School of Medicine at Mount Sinai

OTHER